{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:02Z","timestamp":1787026922757,"version":"build-2736575974"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00755","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:33:36Z","timestamp":1563842016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial"],"prefix":"10.3389","volume":"10","author":[{"given":"Clementina","family":"Sitzia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Meregalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Belicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Farini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Bestetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/bmj.317.7164.991","article-title":"The muscular dystrophies","volume":"317","author":"Emery","year":"1998","journal-title":"BMJ."},{"key":"B2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/hmg\/ddn376","article-title":"Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy","volume":"18","author":"Villalta","year":"2009","journal-title":"Hum Mol Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1010966","DOI":"10.1080\/21675511.2015.1010966","article-title":"The immune system in Duchenne muscular dystrophy: friend or foe","volume":"3","author":"Villalta","year":"2015","journal-title":"Rare Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nmd.2011.08.001","article-title":"Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies","volume":"22","author":"Kobayashi","year":"2012","journal-title":"Neuromuscul Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1179\/174313209X380847","article-title":"The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)","volume":"32","author":"Angelini","year":"2010","journal-title":"Neurol Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1212\/WNL.56.11.1472","article-title":"The earliest pathologic alterations in dysferlinopathy","volume":"56","author":"Selcen","year":"2001","journal-title":"Neurology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1002\/mus.880181312","article-title":"Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses","volume":"2","author":"Arahata","year":"1995","journal-title":"Muscle Nerve Suppl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-017-0563-x","article-title":"Muscle microdialysis to investigate inflammatory biomarkers in facioscapulohumeral muscular dystrophy","volume":"55","author":"Tasca","year":"2018","journal-title":"Mol Neurobiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/(SICI)1097-4598(199806)21:6<769::AID-MUS9>3.0.CO;2-5","article-title":"Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient","volume":"21","author":"Angelini","year":"1998","journal-title":"Muscle Nerve."},{"key":"B10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mus.20812","article-title":"The role of corticosteroids in muscular dystrophy: a critical appraisal","volume":"36","author":"Angelini","year":"2007","journal-title":"Muscle Nerve."},{"key":"B12","first-page":"9","article-title":"Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy","volume":"31","author":"Angelini","year":"2012","journal-title":"Acta Myol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"E594","DOI":"10.3390\/nu9060594","article-title":"Nutritional challenges in Duchenne muscular dystrophy","volume":"9","author":"Salera","year":"2017","journal-title":"Nutrients."},{"key":"B14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/s-0032-1329199","article-title":"The muscular dystrophies","volume":"32","author":"Flanigan","year":"2012","journal-title":"Semin Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/187153012799279045","article-title":"Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases","volume":"12","author":"Reeves","year":"2012","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"B16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ana.23989","article-title":"Therapeutic advances in muscular dystrophy","volume":"74","author":"Leung","year":"2013","journal-title":"Ann Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/MOP.0b013e328365ace5","article-title":"Muscular dystrophy: new challenges and review of the current clinical trials","volume":"25","author":"Mercuri","year":"2013","journal-title":"Curr Opin Pediatr."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2019.006.","article-title":"Gene delivery for limb-girdle muscular dystrophy type 2D by isolated limb infusion","author":"Mendell","year":"2019","journal-title":"Hum Gene Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.nmd.2010.03.005","article-title":"The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009","volume":"20","author":"Muntoni","year":"2010","journal-title":"Neuromuscul Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.nmd.2018.06.009","article-title":"Personalized gene and cell therapy for Duchenne muscular dystrophy","volume":"28","author":"Barthelemy","year":"2018","journal-title":"Neuromuscul Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1212\/NXG.0000000000000323","article-title":"Antisense oligonucleotides: a primer","volume":"5","author":"Scoles","year":"2019","journal-title":"Neurol Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1038\/srep15878","article-title":"Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle","volume":"5","author":"Choi","year":"2015","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/15216549800201772","article-title":"The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice","volume":"44","author":"Lonnrot","year":"1998","journal-title":"Biochem Mol Biol Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12263-011-0222-1","article-title":"Epigenetic changes induced by curcumin and other natural compounds","volume":"6","author":"Reuter","year":"2011","journal-title":"Genes Nutr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.celrep.2016.05.009","article-title":"A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E713","DOI":"10.3390\/nu8110713","article-title":"Nutraceuticals and their potential to treat duchenne muscular dystrophy: separating the credible from the conjecture","volume":"8","author":"Woodman","year":"2016","journal-title":"Nutrients."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1212\/WNL.54.9.1848","article-title":"Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study","volume":"54","author":"Walter","year":"2000","journal-title":"Neurology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1203\/00006450-199802000-00011","article-title":"Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy","volume":"43","author":"Hankard","year":"1998","journal-title":"Pediatr Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0960-8966(01)00273-5","article-title":"Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice","volume":"12","author":"Passaquin","year":"2002","journal-title":"Neuromuscul Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1096\/fj.05-4821fje","article-title":"Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort","volume":"20","author":"Archer","year":"2006","journal-title":"FASEB J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/ajcn\/83.4.823","article-title":"Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy","volume":"83","author":"Mok","year":"2006","journal-title":"Am J Clin Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"680615","DOI":"10.1155\/2015\/680615","article-title":"Improvement of endurance of DMD animal model using natural polyphenols","volume":"2015","author":"Sitzia","year":"2015","journal-title":"Biomed Res Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"14659","DOI":"10.1038\/s41598-018-32613-w","article-title":"Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice","volume":"8","author":"Banfi","year":"2018","journal-title":"Sci Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","article-title":"Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry","volume":"155","author":"Connuck","year":"2008","journal-title":"Am Heart J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JND-160194","article-title":"Cardiac involvement classification and therapeutic management in patients with Duchenne muscular dystrophy","volume":"4","author":"Fayssoil","year":"2017","journal-title":"J Neuromuscul Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.19082\/5732","article-title":"Evaluation of cardiac functions in children with Duchenne muscular dystrophy: a prospective case-control study","volume":"9","author":"Sadek","year":"2017","journal-title":"Electron Physician."},{"key":"B41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/WCO.0b013e32834aa38d","article-title":"Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches","volume":"24","author":"Nigro","year":"2011","journal-title":"Curr Opin Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3233\/JND-150105","article-title":"The classification, natural history and treatment of the limb girdle muscular dystrophies","volume":"2","author":"Murphy","year":"2015","journal-title":"J Neuromuscul Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1212\/WNL.0000000000001519","article-title":"Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E","volume":"84","author":"Semplicini","year":"2015","journal-title":"Neurology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mus.25192","article-title":"The italian limb girdle muscular dystrophy registry: relative frequency, clinical features, and differential diagnosis","volume":"55","author":"Magri","year":"2017","journal-title":"Muscle Nerve."},{"key":"B45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/16501970410023461","article-title":"Functional status and muscle strength in people with Duchenne muscular dystrophy living in the community","volume":"36","author":"Uchikawa","year":"2004","journal-title":"J Rehabil Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1469-8749.2012.04345.x","article-title":"A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy","volume":"54","author":"Mazzone","year":"2012","journal-title":"Dev Med Child Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1371\/currents.md.1ced64dff945f8958221fddcd4ee60b0","article-title":"Can quantitative muscle strength and functional motor ability differentiate the influence of age and corticosteroids in ambulatory boys with Duchenne muscular dystrophy?","volume":"8","author":"Buckon","year":"2016","journal-title":"PLoS Curr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/jcsm.12347","article-title":"Relationships between muscle size, strength, and physical activity in adults with muscular dystrophy","volume":"9","author":"Jacques","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1055\/s-0031-1295478","article-title":"Functional taping applied to upper limb of children with hemiplegic cerebral palsy: a pilot study","volume":"42","author":"Mazzone","year":"2011","journal-title":"Neuropediatrics."},{"key":"B50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2377-12-91","article-title":"Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures","volume":"12","author":"Lerario","year":"2012","journal-title":"BMC Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study","volume":"48","author":"McDonald","year":"2013","journal-title":"Muscle Nerve."},{"key":"B52","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.3390\/v9060141","article-title":"The human gut phage community and its implications for health and disease","volume":"9","author":"Manrique","year":"2017","journal-title":"Viruses."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/cphy.c170052","article-title":"Immunobiology of inherited muscular dystrophies","volume":"8","author":"Tidball","year":"2018","journal-title":"Compr Physiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/clim.2000.4966","article-title":"Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle","volume":"98","author":"Spencer","year":"2001","journal-title":"Clin Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/path.2213","article-title":"T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid\/mdx mouse","volume":"213","author":"Farini","year":"2007","journal-title":"J Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"FASEB J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2353\/ajpath.2008.070327","article-title":"Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B","volume":"172","author":"Nagaraju","year":"2008","journal-title":"Am J Pathol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/mt.2016.162","article-title":"Therapeutic potential of immunoproteasome inhibition in Duchenne muscular dystrophy","volume":"24","author":"Farini","year":"2016","journal-title":"Mol Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0278-6915(03)00005-X","article-title":"Inactivation of creatine kinase induced by quercetin with horseradish peroxidase and hydrogen peroxide. pro-oxidative and anti-oxidative actions of quercetin","volume":"41","author":"Miura","year":"2003","journal-title":"Food Chem Toxicol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"825928","DOI":"10.1155\/2013\/825928","article-title":"Polyphenols in exercise performance and prevention of exercise-induced muscle damage","volume":"2013","author":"Malaguti","year":"2013","journal-title":"Oxid Med Cell Longev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1212\/WNL.0b013e31824c46be","article-title":"Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trial","volume":"78","author":"Escolar","year":"2012","journal-title":"Neurology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.nmd.2011.02.016","article-title":"Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial","volume":"21","author":"Buyse","year":"2011","journal-title":"Neuromuscul Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3233\/JND-170245","article-title":"Efficacy of idebenone to preserve respiratory function above clinically meaningful thresholds for Forced Vital Capacity (FVC) in patients with Duchenne muscular dystrophy","volume":"4","author":"Mayer","year":"2017","journal-title":"J Neuromuscul Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2014.09.014","article-title":"Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial","volume":"81","author":"Passerieux","year":"2015","journal-title":"Free Radic Biol Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.biocel.2006.09.009","article-title":"Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions","volume":"39","author":"Radley","year":"2007","journal-title":"Int J Biochem Cell Biol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:33:40Z","timestamp":1563842020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":65,"alternative-id":["10.3389\/fneur.2019.00755"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00755","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"article-number":"755"}}